Full Text
Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients

Abstract

Authors

KJ Russell J Janssens A Dean A Hernandez A Voss

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×